InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,460.24
(
0.61%
)
US TECH 100
18,525.60
(
-0.05%
)
Dow Jones
40,201.17
(
0.87%
)
Brent Oil
81.18
(
0.54%
)
Bitcoin
64,841.62
(
-0.81%
)
Post# of 252672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: DewDiligence post# 154101

Friday, 12/14/2012 12:19:07 PM

Friday, December 14, 2012 12:19:07 PM

Post# of 252672
PPHM:

Out of the box thinking. The NIH buys Peregrine for $50 billion. They then run trials on all cancers. Bavi is provided at cost to all patients. Medicare costs plummet.



That's going to be devastating for a lot of researchers since the NIH annual budget is ~35 billion.

But if the NIH is going to go into hock for a drug, it should obviously be bavi.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up